Inspection Findings:
2.
Infection Prevention and Control (IPC) Program
Facility policy Infection Control Policies and Practices, adopted 12/15/2021, documented the policy was to facilitate maintaining a safe, sanitary, and comfortable environment and to help prevent and manage transmission of diseases and infections. The program's objectives included ...."e. Maintain records of incidents and corrective actions related to infections ...3. The Quality Assurance Performance Improvement (QAPI) Committee, through the Infection Control Committee, oversees implementation of the infection control policies and practices, and assists department heads and managers to validate that they are implemented and followed .....5. The Administrator or Governing Body, through the QAPI and Infection Control Committees, have adopted our infection control policies and practices, as outlined herein, to reflect the Center's needs and operational requirements for preventing transmission of infections and communicable diseases as set forth in current OBRA (Omnibus Budget Reconciliation Act), OSHA (Occupational Safety and Health Administration), and CDC (Centers for Disease Control and Prevention) guidelines and recommendations."
Review of CDC Long-term Care Facilities Nursing Home Infection Preventionist Training, dated March 28, 2024, accessed 11/21/24, https://www.cdc.gov/long-term-care-facilities/hcp/training/index.html, outlined specialized training covered core activities of effective IPC programs. Surveillance is a core activity of a nursing home's infection prevention and control, or IPC, program. Surveillance was the ongoing, systematic collection, analysis, interpretation, and dissemination of data. The purpose of surveillance is to identify infections and to monitor adherence to recommended IPC practices in order to reduce infections and prevent the spread of pathogens among residents, staff, and visitors. An IPC program uses surveillance data to monitor trends in infections and pathogens, including detecting outbreaks in the facility ....and to identify performance improvement opportunities. Outcome measures identify specific infection events, for both infections and pathogens, to monitor among residents and staff. When conducting surveillance, each outcome or process measure that is being monitored should be clearly defined using standard criteria so that data elements are collected in a consistent way, which ensures accuracy and reproducibility regardless of who is performing the surveillance .....Using the same definitions and methods to track infections or adherence to IPC practices allows your program to compare these data over time."
Review of facility's last three Infection Surveillance Monthly Reports, dated August 2024, September 2024, and October 2024, showed each month's report included a line graph for the number of infections in the facility that month, Summary by Infection Category, and then table detailing each resident's infection with infection onset, infection type, signs and symptoms, status and pharmacy order, and comments. The table did not include pathogen or organism data collected for each infection. August showed zero infections but there were no details for Infection Category or resident details and appeared to be an incomplete report. September showed 2 Bone & Joint infections, 1 Ear, Nose, Mouth & Throat infection, and five Other infections. The details for the Other infections included an infection with comments about resident having an urinary tract infection without catheterization and another resident with abnormal lung examination, cough and fatigue. Two residents did not have any signs and symptoms entered and zero of the residents had a pathogen or organism identified or documented. The October 2024 report was very similar to September 2024 with four Other infections, two residents without any signs and symptoms of infections entered and zero of the residents had a pathogen or organism identified or documented. There was no documented evidence of facility mapping by infections or organisms.
During a concurrent joint record review and interview on 11/21/24 at 10:10 AM Infection Preventionist (IP) reviewed August, September, October monthly Infection Surveillance Monthly reports. When asked how infections were categorized by infection type and what criteria was used to determine infection type category, IP stated that McGeer's criteria was used. When asked to provide McGeer's criteria used, IP stated that she would provide at a later time. McGeer's or criteria used to categorize infection type was not provided. When asked why there were so many infections categorized under "Other", IP stated that sometimes "Other" is used because they don't have enough information initially, however when additional information becomes available the Other category is not changed to a more specific infection type such as Lower Respiratory Tract Infection, Skin Infection, or Urinary Tract Infection. When asked how analysis, trends or actions can be taken if the majority of infections are categorized or miscategorized under "Other", IP stated that she was not sure how to answer that. When asked to provide written Infection Control program's monthly data analysis, identification of trends, rates of health care associated infections showing trends over time and compared to baseline or regional or national trends, IP stated that she would look for that. When asked for monthly written reports shared at Infection Control committee meeting or QAPI meeting. IP stated that she had been in the IP role since 11/4/24 but had completed the CDC IP Nursing Home course and provided a copy of course completion certificate. IP stated that she would ask previous IP (Resident Care Manager, RCM2) and DON for written IPC reports and responses to questions.
During an interview on 11/22/24 at about 12:30 PM, IP stated that she could not find written IPC reports showing data analysis and actions based on analysis that was presented to IC or QAPI meetings and deferred to DON.
During a concurrent interview and joint record review on 11/22/24 at 1:35 PM with DON and Administrator Aug, Sept, Oct Infection surveillance monthly reports were reviewed. DON stated that some of the residents were miscategorized under OTHER and should have been categorized or identified with urinary, skin or lower respiratory infections instead. When asked about written IPC reports showing data analysis, trends over time, comparison to benchmarks, and reported to IC or QAPI committees, DON stated that there was no IPC written reports and more oversight was needed for the IPC program. DON stated that over the past year, there has been a different person in the IP role every couple of months. DON listed 5 different individuals who held IP role in the past year.
3.
Not following disinfecting wipes manufacturer's instructions when cleaning glucometers
Observation on 11/20/24 at 11:20 AM showed LPN19 exit R6's room with Evencare Proview glucometer, place glucometer on treatment cart, remove one wipe from Microkill container and quickly wipe glucometer with brisk motions and then within seconds placed glucometer in cart drawer, close drawer and walked down the hallway. LPN19 then gathered glucometer supplies and stated she would be checking blood sugars for residents on that hall now.
During a concurrent observation and interview on 11/20/24 at 11:45 AM showed LPN19 pricking R137's finger with lancet with a bead of blood produced. LPN19 brought strip in glucometer to bead of blood with blood sugar reading obtained. LPN19 then exited room and placed glucometer on cart, removed one Microkill wipe from container and wiped glucometer's surfaces and then placed glucometer back on cart and discarded wipe. LPN19 then opened cart drawer and removed another glucometer. After 30 seconds, glucometer that LPN19 wiped was picked up and was observed to be dry to touch. When asked why glucometers were wiped after use on resident, LPN19 stated that we are trying to kill everything on it as we don't want to spread bacteria and infection since we are using these for everybody. When asked about the process for using wipes on glucometer, LPN19 stated that we wipe glucometer and then leave it there, there's a 1-2 minute drying period between uses. LPN19 stated that prior to use on R137, the glucometer was used on R8. When asked if when using wipes if the glucometers needed to be wet for a certain period of time, LPN19 shook her head and stated that glucometers are just wiped and don't need to be wet for a certain period of time. Joint review of the Microkill disinfecting wipes label documented that the treated surface needed to remain visibly wet for one minute to kill the organisms on the label. When asked if the glucometer remained visibly wet for one minute, LPN19 shook her head and said "no".
During an interview on 11/21/24 at 10:10 AM IP stated that manufacturer's instructions for wipes for cleaning and disinfecting glucometers should be followed. When asked about the process for cleaning/disinfecting glucometers, IP stated that the contact/dry/wet time is "the amount of time that the nurses have to allow device to dry and they can't use it, they either wrap the device in wipe or scrub it continuously." Joint review of Microkill wipe container's label showed the device needs to remain visibly wet for the time indicated to kill pathogens.
During an interview on 11/21/2024 at 12:33 PM IP stated that the contact time, dry time and wet time has been discussed with staff today and yesterday. She stated that she prefers if staff wrap glucometer with wipe and let glucometer sit there. IP nodded that facility policy focuses on dry time and not wet time, which may be confusing to staff.
Review of Micro-Kill One manufacturer's materials showed "Micro-Kill One contact time for a disinfectant is the amount of time a surface must remain wet with the product to achieve disinfection."
Facility policy Disinfection of Point-of-Care Devices/Instrument, dated 8/1/24, documented "all point-of-care devices i.e. Glucometers will be cleaned and disinfected according to manufacturer's recommendations using EPA (Environmental Protection Agency) approved disinfectants. a. Care will be taken to assure the cleaning product has been allowed to dry per manufacturer's recommendation (dwell time). b. When possible the facility will be equipped with two glucometers per area. Glucometers will be used alternately to allow for adequate dwell (dry) time after disinfecting." The facility's policy focused on dry time whereas the disinfecting wipe focused on wet time.
Review of R137's Medication Administration Record, dated November 2024, documented staff were to check resident's CBG (capillary blood glucose) before meals and at bedtime related to diabetes. Start date 10/7/24.
4.
Not performing hand hygiene
Review of R20's records documented resident was admitted on 6/8/24 with diagnoses including quadriplegia (partial or total loss of movement and sensation in all four limbs and body), diabetes, pressure ulcer of sacral region, stage 4, and neuromuscular dysfunction of bladder (condition in which a person lacks urinary bladder control due to brain, spinal cord or nerve problems).
Review of R20's care plan documented resident had an indwelling urinary catheter (a flexible tube inserted to the bladder to drain urine).
Review of R20's current physician orders documented Sacrum Wound: Clean with wound cleanser. Apply skin prep to periwound (skin edges around wound) and allow to dry. Gently Pack with 1/4 strength dakins (wound care solution that is a diluted bleach solution with other ingredients) moistened gauze into wound and cover with bordered foam dressing every other day and back MASD (moisture associated skin damage, caused by prolonged exposure to various sources of moisture, including urine or stool, perspiration, wound exudate, mucus, saliva, and their contents. MASD is characterized by inflammation of the skin) to cleanse with soap and water, pat dry and apply silvadene (topical cream to treat and prevent wound infections) cream.
Observation on 11/19/24 at 8:54 AM showed staff changing R20's sacral wound dressing. Certified Nursing Assistant (CNA)9, DON, RCM2, and Wound Care Nurse (WCN) were assisting with wound care. The following supplies were prepared in the resident's room, Optifoam gentle, silver sulfadiazine cream 1%, cotton swab sticks, 6x6 gauze dressing, Dakin's solution, cup with gauze in Dakin's solution and the resident's tv stand shelf had two basin containers filled with wound care supplies. WCN with headlamp and gown and gloves on removed resident's sacral and mid back dressings. Without performing hand hygiene after removing dirty dressings, WCN took pictures of wound and then placed measuring tape near sacral wound and placed cotton tipped sticked into wound. Using the same gloves, WCN then sprayed gauze with skin integrity wound cleanser and patted resident's back in several location with the gauze. DON packed sacral wound with gauze and applied Optifoam dressing and dated dressing. Immediately after wound observation, WCN left the facility for the rest of the week and was not available to be interviewed.
During an interview on 11/19/24 at 9:20 AM DON was informed of observation of WCN not performing hand hygiene between dirty and clean tasks when changing gloves but should have.
During an interview on 11/21/2024 at 12:33 PM IP stated that the facility policy when going from a dirty to clean task, is to remove gloves, wash hands or hand hygiene and then apply new gloves. When informed of observation of WCN, IP stated that WCN did not follow facility's policy for hand hygiene.
Facility policy Hand Hygiene, dated 8/1/24, documented "Hand hygiene is the primary means of preventing the transmission of infection ...." The following were situations that required hand hygiene ...."r. after handling soiled or used linens, dressings .....u. after removing gloves ...; and/or before applying ..." ..."
, Based on observation, interview and record review, the facility failed to establish and maintain an infection prevention and control program designed to provide a safe and sanitary environment to help prevent the transmission of communicable diseases. In addition, the facility failed to develop and implement a system for preventing, identifying, reporting, investigating, and controlling infections and communicable diseases for its residents. The facility census was 46. Specifically:
1. The facility failed to disinfect glucometers between and/or prior to use for four of four residents (Resident (R) 8, R 10, R 11, and R 90) observed receiving blood glucose testing. The failure to disinfect glucometers between residents observed on 11/20/24 from 07:40 AM to 08:02 AM placed 13 residents (R4, R6, R8, R9, R10, R11, R19, R20, R26, R28, R86, R136, and R137) who required daily blood glucose testing, 1 resident (R32) who required PRN (as needed) blood glucose testing, and 1 resident (R90) requiring fasting blood glucose testing at risk for serious and potentially life-threatening blood-borne illness; this constituted immediate jeopardy. On 11/20/24 at 10:13 AM the facility's Administrator and Administrator in Training was notified of an Immediate Jeopardy (IJ) determination.
The facility provided an acceptable Removal Plan which included putting residents who may have been affected on alert for potential exposure to a blood-born pathogen, and retraining and ensuring competency of all Licensed Practical Nurses (LPN) and Registered Nurses (RN) on the use and sanitization of glucometers. Through interviews with facility staff, observations of glucose testing, and review of staff in-services, the survey team verified implementation and removed the Immediate Jeopardy on 11/21/24 at 05:54 PM. The deficient practice remained at a scope and severity of pattern, no actual harm with potential for more than minimal harm following the removal of the immediate jeopardy.
2. Failed to ensure infection surveillance outcome data was clearly defined using standard criteria to facilitate identifying, tracking, analyzing and preventing infections, and facility failed to analyze, interpret, develop and provide written reports to Infection Control and/or Quality Assessment and Assurance meetings.
3. Failed to follow disinfecting wipes manufacturer's instructions when cleaning glucometer for 1 of 13 resident (R137) observations.
4. Failed to ensure staff performed hand hygiene between dirty and clean tasks during 1 of 2 sampled resident (R20) wound care observation.
Findings include
1.
Not cleaning and disinfecting glucometers
Review of CDC Viral Hepatitis Basics, dated 7/30/24, at https://www.cdc.gov/hepatitis/about/index.html documented "viral hepatitis is a disease of the liver caused by a virus. Untreated, viral hepatitis can lead to serious liver problems, like scarring or cancer. Even if you don't have symptoms, you can spread viral hepatitis .....with many people not even realizing they are infected ...Hepatitis B [HBV] is contagious and ...primarily spread when blood ...or certain other bodily fluids-even microscopic amounts-from a person infected with HBV enter the body of someone who is not infected .....Many people with hepatitis C [HCV] don't look or feel sick, so they might not know they have the virus ...Hepatitis C usually doesn't have symptoms ....Hepatitis C is spread when blood from a person infected with HCV-even microscopic amounts-enters the body of someone who is not infected." The CDC website provides information about viral hepatitis transmission risk and prevention approaches for specific high risk populations and settings, including people with human immunodeficiency virus, people who use or inject drugs, people who experience homelessness.
R19
Review of a Quarterly Minimum Data Set (MDS) with an Assessment Reference Date (ARD) of 10/11/24, indicated R 19 was cognitively intact with a Brief Interview for Mental Status (BIMS) score of 15. The assessment included that R 19 had active diagnoses of Diabetes Mellitus (a chronic disease that occurs when the body can't produce or use insulin properly) and Viral Hepatitis.
R26
The facility provided resident profile documentation that R 26, admitted to the facility in 2024, had a history of drug use. A provider note dated 11/12/24 included that R 26 used "meth" (Methamphetamine also known as meth or crystal meth is a very addictive drug which can be smoked, snorted or injected directly into the bloodstream Injecting meth is linked with diseases like HIV and hepatitis C.)
R11
Review of a Quarterly MDS in August 2024, indicated R 11 was cognitively intact with a BIMS score of 15. The assessment included that R 11 had active diagnoses of Diabetes Mellitus, hyperthyroidism (a medical condition that occurs when the thyroid gland produces too much thyroid hormone, which speeds up the body's metabolism), and cataracts (a clouding of the eye's lens that reduces vision). R11 was admitted to facility in 2024.
Review of a Progress Note dated 11/04/24 revealed R 11's past medical history included being homeless and imprisonment.
Review of resident profile data dated 11/22/24, collected by the facility, revealed that R 11 was homeless.
R8
Review of a Quarterly Minimum Data Set (MDS) with an Assessment Reference Date (ARD) of 08/30/24, indicated R 8 was cognitively intact with a BIMS score of 15. The assessment included that R 8 had active diagnoses of Diabetes Mellitus, depression, and long-term or current use of insulin.
R10
Review of a Quarterly Minimum Data Set (MDS) with an Assessment Reference Date (ARD) of 10/01/24, indicated R 10 had moderate cognitive impairment with a BIMS score of 11. The assessment included that R 10 had active diagnoses of Diabetes Mellitus, fatty liver, and long-term or current use of insulin.
During a medication administration observation on 11/20/24 at 07:40 AM, Licensed Practical Nurse (LPN) 1 had cleaned a glucometer with an alcohol wipe, donned (put on) a pair of gloves and then entered R 11's room. LPN 1 instructed the resident that she was going to test blood sugar and wiped the resident's finger with another alcohol pad. LPN 1 pricked resident's finger with the lancet and squeezed the finger to form a bead of blood. LPN 1 brought the glucometer with the strip in the glucometer to the bead of blood. The bead of blood ran down the strip and registered the blood sugar reading. After obtaining the blood sugar reading, LPN 1 removed (doffed) their gloves and returned to the medication cart. LPN 1 placed a tissue on the top of the cart and placed the glucometer on top of the tissue. LPN 1 accessed the electronic medical record (EMR) and documented the blood sugar result. After documenting, LPN 1 locked the cart and pushed it west down the hallway to R 8's room.
LPN 1 was not observed cleaning or disinfecting the contaminated glucometer from R 11's room to R 8's room.
During another medication administration observation with the same medication cart and LPN on 11/20/24 at 07:44 AM, LPN 1 completed hand hygiene, opened the top drawer to remove a new testing strip, 2 x 2 gauze, and alcohol pad. LPN 1 completed hand hygiene again, donned new gloves, collected the same glucometer from the tissue on top of the cart, and entered R 8's room. After completing the finger stick glucose monitoring (same steps as observed for previous resident), LPN 1 returned to the medication cart at 11/20/24 at 07:51 AM placed the same glucometer on the same tissue on top of the cart, doffed her gloves, and performed hand hygiene. LPN 1 moved the cart south towards R 10's room.
Review of a Quarterly Minimum Data Set (MDS) with an Assessment Reference Date (ARD) of 08/30/24, indicated R 8 was cognitively intact with a BIMS score of 15. The assessment included that R 8 had active diagnoses of Diabetes Mellitus, depression, and long-term or current use of insulin.
Again, LPN 1 was not observed cleaning or disinfecting the glucometer from R 8's room to R 10's room.
During another medication administration observation with the same medication cart and LPN on 11/20/24 at 07:51 AM, LPN 1 performed hand hygiene, donned gloves, then doffed gloves, then donned gloves again to enter R 10's room at 07:53 AM. LPN 1 completed the blood glucose monitoring (same steps as observed for previous resident), blood sugar reading was 102 and gave 32 units of insulin. Returned to the cart at 07:55 AM, LPN 1 laid the same glucometer back on top of the cart, doffed gloves, and completed hand hygiene. At 07:56 AM, LPN 1 removed a bag from the cart that held the insulin pen for R10 and laid the bag on top of the glucometer. LPN 1 completed hand hygiene prior to placing the insulin pen in the bag and then returned the bag to the drawer. LPN 1 moved the medication cart south again to R 90's room.
Review of a Quarterly Minimum Data Set (MDS) with an Assessment Reference Date (ARD) of 10/01/24, indicated R 10 had moderate cognitive impairment with a BIMS score of 11. The assessment included that R 10 had active diagnoses of Diabetes Mellitus, fatty liver, and long-term or current use of insulin.
Again, LPN 1 was not observed cleaning or disinfecting the glucometer from R 10's room to R 90's room.
During another medication administration observation with the same medication cart and LPN on 11/20/24 at 07:56 AM, LPN 1 was observed performing hand hygiene again and donning new gloves. At 07:57 AM doffed gloves to get new glucometer strip for machine then donned new gloves. LPN 1 wiped R 90's finger with another alcohol pad. LPN 1 pricked resident's finger with the lancet and squeezed the finger to form a bead of blood. LPN 1 brought the glucometer with the strip in the glucometer to the bead of blood. LPN 1 stated that R 90 was only having a fasting blood sugar test. At 07:58 AM LPN 1 doffed gloves, completed hand hygiene, donned new gloves. At 08:00 AM LPN donned new gloves and cleaned glucometer with a "micro-kill one germicidal alcohol wipe." LPN 1 wrapped the glucometer in the wipe and placed it on the top of the cart. At that time, LPN 1 removed a second glucometer from the drawer, wiped it with another micro-kill one wipe, wrapped it, and placed it on top of the cart next to the other glucometer.
During the observation from 07:40 AM to 8:02 AM, LPN 1 only removed two wipes from the micro-kill one germicidal alcohol wipe container on the medication administration cart at the end of the glucometer checks when LPN 1 cleaned two glucometers at the same time.
During an interview conducted on 11/20/24 at 08:02 AM, LPN 1 stated the glucometers are to be cleaned in between each resident. When asked why she didn't disinfect in between each resident, LPN 1 said, "I didn't?" When asked what the potential complications would be of not disinfecting between residents, LPN 1 said it would be an infection control risk. LPN 1 stated she thought she had disinfected between each resident. When asked where the second glucometer had been LPN 1 stated, "in the drawer." When asked if she was cleaning them together at the same time, LPN 1 said, "yes." LPN 1stated it was a one-minute wet time when using the wipes [micro-kill one germicidal alcohol wipe].
During an interview on 11/20/24 at 08:52 AM, LPN 2 stated that she uses the microbial white cleaning wipe [micro-kill one germicidal alcohol wipe] after the last patient in a glucometer "run". LPN 2 described a run as being 5 residents. LPN 2 stated that in-between residents, she uses an alcohol wipe because the "microbial wipes" cause cancer and she doesn't want to expose herself or the residents to that any more than needed. LPN 2 identified the "microbial wipes" as the micro-kill one germicidal alcohol wipe.
On 11/20/24 at 10:30 AM an interview was conducted with the Director of Nursing (DON), Administrator, and Administrator in Training (AIT). The DON stated that the expectation is for staff to clean the glucometers following manufacturer's guidelines. When asked if the nursing staff should limit the amount of exposure to the micro-kill one germicidal alcohol wipe because the wipes "cause Cancer", the DON did not comment. The DON stated that LPN 1 stated they had "swapped out" [alternating between] the glucometers between each resident. The DON stated that the staff stated that they did disinfect between each resident but acknowledged that comments that using the micro-kill one germicidal alcohol wipe could expose the resident's to cancer were inaccurate.
On 11/21/24 at about 9:30 AM LPN2 asked surveyor why cleaning glucometers with only alcohol was not enough as this is what she was taught in school and has been her practice. Informed LPN2 that CDC recommends glucometers not to be shared between residents but if glucometers are shared then manufacturer's instructions for cleaning and disinfecting glucometers needed to be done to prevent the spread of blood borne infections.
Review of facility's immediate jeopardy removal plan, dated 11/20/24, and facility records documented that 13 residents (R4, R6, R8, R9, R10, R11, R19, R20, R26, R28, R86, R136, and R137) required daily blood glucose testing, 1 resident (R32) required PRN (as needed) blood glucose testing, and 1 resident (R90) required fasting blood glucose testing.
Review of the "Evencare Proview Blood Glucose Monitoring System User's Guide" [what is date of guide, or state undated] included that the healthcare professionals should "adhere to standard precautions when handling or using this device. All parts of the glucose monitoring system should be considered potentially infectious and are capable of transmitting blood-borne pathogens between patients and healthcare professionals ...Glucose meters used in a clinical setting for testing multiple persons must be cleaned and disinfected between patients." The guide also included that only "one disinfectant should be used on the device for the life of the device, as the effect of using more than one disinfectant interchangeably has not been evaluated." The guide included the following:
Disinfection Instructions:
The meter must be disinfected between patient uses by wiping it with a [brand name] towelette or EPA-registered disinfecting wipe in between tests and be cleaned prior to disinfecting. The Disinfection process reduces the risk of transmitting infectious diseases if it is performed properly.
Review of a facility policy titled "Disinfection of Point-of-Care Devices/Instruments" adopted 08/01/24 included the facility's policy is to "protect residents from cross contamination of blood-borne pathogens and/or other potential infectious materials by assuring other instruments and point-of-care devices are properly cleaned and disinfected." The policy included that all "point-of-care devices i.e. Glucometers, Coagu-chek meters will be cleaned and disinfected according to manufacturer's recommendation using EPA approved disinfectants ... When possible, the facility will be equipped with two glucometers per area. Glucometers will be used alternately to allow for adequate dwell (dry) time after disinfecting."
Review of a facility policy titled "Infection Control Policies and Practices" adopted 12/15/21 included that policy's intention is to "facilitate maintaining a safe, sanitary, and comfortable environment and to help prevent and manage transmission of diseases and infections." The policy included objectives to prevent and control infections, and to provide guidelines for the safe cleaning and reprocessing of reusable resident-care equipment. The facility has adopted infection control policies and practices to reflect preventing transmission of infections and communicable disease as set forth in current CDC (Centers for Disease Control and Prevention) guidelines and recommendations.
CDC Infection Prevention during Blood Glucose Monitoring and Insulin Administration, dated 2/6/13 at https://www.cdc.gov/cliac/docs/addenda/cliac0313/07B_CLIAC_2013March_Glucose_Monitoring.pdf, documented "The CDC has become increasingly concerned about the risks for transmitting hepatitis B virus (HBV) and other infectious diseases during assisted blood glucose (blood sugar) monitoring and insulin administration. CDC is alerting all persons who assist others with blood glucose monitoring and/or insulin administration of the following infection control requirements: ....
*whenever possible, blood glucose meters should not be shared. If they must be shared, the device should be cleaned and disinfected after every use, per manufacturer's instructions .....An underappreciated risk of blood glucose testing is the opportunity for exposure to bloodborne viruses (HBV, hepatitis C virus, and HIV)[Human immunodeficiency virus] through contaminated equipment and supplies if devices used for testing and/or insulin administration (e.g., blood glucose meters ....) are shared. Outbreaks of hepatitis B virus (HBV) infection associated with blood glucose monitoring have been identified with increasing regularity, particularly in long-term care settings, such as nursing homes ..., where residents require assistance with monitoring of blood glucose levels ...In the last 10 years alone, there have been at least 15 outbreaks of HBV infection associated with providers failing to follow basic principles of infection control when assisting with blood glucose monitoring. Due to under-reporting and under recognition of acute infection, the number of outbreaks due to unsafe diabetes care practices identified to date are likely an underestimate ....Blood glucose meters are devices that measure blood glucose levels. Whenever possible, blood glucose metes should be assigned to an individual person and not be shared. If he blood glucose meter must be shared, the device should be cleaned and disinfected after every use, per manufacturer's instructions, to prevent carry-over of blood and infectious agents ..."
CDC Frequently Asked Questions (FAQs) regarding Assisted Blood Glucose Monitoring and Insulin Administration, undated, at www.cdc.gov/injectionsafety/providers/blood-glucose-monitoring_faqs.html documented "Infectious agents, such as HBV, can be transmitted through indirect contact transmission, even in the absence of visible blood. Indirect contact transmission is defined as the transfer of an infectious agent (e.g., HBV) from one patient to another through a contaminated intermediate object (e.g., blood glucose meter) or person (e.g., healthcare personnel hands). With some blood glucose meters that require pre-loading of the test strip, the device may come into direct or close contact with the patient's fingerstick wound. If blood is transferred from the patient to the meter, and the meter is not cleaned and disinfected after use, subsequent patients can be exposed to this blood when the meter is used on them. Indirect contact transmission can also occur even if the patient never directly contacts the meter. Healthcare personnel hands can become contaminated with blood at various points while performing assisted blood glucose monitoring including pricking the patient's finger or handling the test strip. Blood can then be transferred to the meter when healthcare personnel handle the meter to obtain the reading. If the meter is not cleaned and disinfected after use, the blood remaining on the meter can be transferred to subsequent patients via healthcare personnel hands when they handle the meter and then assist with fingerstick procedures. Numerous outbreaks have implicated this mechanism in the spread of HBV infections ....A multi-hospital study of blood glucose meters found that 30% were contaminated with blood; contamination was identified at the test strip insertion site as well as on the outside surfaces of meters. Further, HBV has been demonstrated to remain infectious in dried blood on environmental surfaces for at least 7 days. For these reasons, blood glucose meters should be cleaned and disinfected after each use, unless they are dedicated to a single patient and appropriately stored to prevent inadvertent contamination."